Perspectives on hypertension treatment in older persons by Stott, David J. & Applegate, William B.
 
 
 
 
 
 
Stott, D. J. and Applegate, W. B. (2018) Perspectives on hypertension 
treatment in older persons. Age and Ageing, (doi:10.1093/ageing/afy055). 
 
This is the author’s final accepted version. 
 
There may be differences between this version and the published version. 
You are advised to consult the publisher’s version if you wish to cite from 
it. 
 
http://eprints.gla.ac.uk/163000/    
                    
 
 
 
 
 
 
Deposited on: 17 July 2018 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk  
 
Age and Ageing editorial 
 
Title: Perspectives on Hypertension Treatment in older persons  
 
Raised blood pressure is probably the single most important treatable risk factor for 
cardiovascular disease in later life. The evidence for benefit from antihypertensive 
drugs in older people has accumulated with a succession of randomized controlled 
trials over the past 35 years, with reduced risk of stroke and myocardial infarction 
as well as decreased total mortality (1). However, despite the extensive evidence 
that is now available, questions remain about who to treat and on optimal blood 
pressure targets. Consequently practice varies widely and many clinicians are 
uncertain about what best to recommend for their older patients.  
 
In this context, Age and Ageing and the Journal of the American Geriatrics Society 
are pleased to contribute to the debate in a joint initiative, publishing two articles 
that describe contrasting perspectives on this issue (2, 3). 
 
The article by Conroy and Westendorp in Age and Aging (2) points out the benefits 
of treatment of hypertension in older persons (particularly in reducing stroke 
rates), however these authors emphasize the need to consider adverse effects and 
warn about problems caused by over-aggressive blood pressure lowering in older 
persons. These authors review issues related to the Systolic Blood Pressure 
Intervention Trial (SPRINT) (4), Heart Outcome Prevention Evaluation (HOPE) (5), 
and Hypertension in the Very Elderly Trial (HYVET) (6) studies and note that the 
participants in these trials are not as sick with multi-morbidity, frailty and 
polypharmacy as are many older persons including in general practice settings. 
They further emphasize the need for shared decision making with patients 
regarding whether or how aggressively to treat. These authors advise clinicians to 
consider a patient’s likely longevity and estimates of the number needed to treat to 
inform patients in their decisions. They recommend the current European blood 
pressure treatment target of 150mmHg systolic and 90 mmHg diastolic, while 
emphasizing clinician and patient judgment in tailoring treatment decisions. 
 
In their article for the Journal of the American Geriatrics Society, Cushman and 
Johnson(3), two leading SPRINT (4) investigators, present a discussion of the recent 
American College of Cardiology and American Heart Association (ACC/AHA) 
guidelines (7) for managing high blood pressure with a special focus on managing 
this disorder in older persons. The article presents a detailed rationale for why the 
US guidelines now recommend lower targets for systolic blood pressure and 
diastolic blood pressure management in older persons. The article nicely 
incorporates their perspectives based on the revised guidelines as well as findings 
from their SPRINT trial. They recommend a blood pressure threshold and treatment 
goal of systolic 130 mmHg and diastolic 80 mmHg in older patients with a 10-year 
cardiovascular disease risk of 10% or more. This includes the vast majority of 
persons over age 65 and all over age 70. This advice is heavily influenced by the 
results of the recent SPRINT trial. Although these authors do express concern over 
the adverse effects of blood pressure lowering, their emphasis rests more on the 
need for clinicians to understand that the recent guidelines and results of the 
SPRINT study warrant a more aggressive approach to treatment goals in older 
persons, particularly those who have high baseline cardiovascular disease risk. 
 
So where does this leave the clinician? For some older people blood pressure 
lowering for prevention of vascular disease will be a high priority, with the potential 
for substantial gains from setting a low treatment target. However for others 
antihypertensive treatment will be irrelevant or even harmful. The decision 
whether or not to treat hypertension in older age, and ‘how low to go’ remain a 
matter of expert clinical judgement, tailoring recommendations for antihypertensive 
treatment to the individual older person’s specific characteristics and wishes.  
 
Authors: 
 
David J Stott 
(orcid.org/0000-0002-3110-7746) 
Editor-in-Chief Age and Ageing 
Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK 
 
William B Applegate 
Editor-in-Chief Journal of the American Geriatrics Society 
 
Address correspondence to; 
 
D J Stott, 2rd floor New Lister Building, Glasgow Royal Infirmary, UK G31 2ER 
email david.j.stott@glasgow.ac.uk 
 
W B Applegate 
address 
email  
 
Conflict of interest: 
None declared. 
 
References: 
 
1. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for 
hypertension in the elderly. Cochrane Database of Systematic Reviews. 
2009(4):Cd000028. 
2. Conroy S and Westendorp R. Hypertension treatment for older people – 
navigating between Scylla and Charybdis.  Age and Ageing; 2018; 47: XXXX-
XXXX. 
3. Cushman WC, Johnson KC. The 2017 U.S. Hypertension Guidelines: What is 
Important for Older Patients. J Amer Geriatr Soc 2018; 66: XXXX-XXXX 
4. SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, 
Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, 
Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius 
WT. A Randomized Trial of Intensive versus Standard Blood-Pressure 
Control. New England Journal of Medicine. 2015;373(22):2103-16. 
5. Lonn EM, Bosch J, Lopez-Jaramillo P, Zhu J, Liu L, Pais P, et al. Blood-
Pressure Lowering in Intermediate-Risk Persons without Cardiovascular 
Disease. New England Journal of Medicine 2016; 374:2009-2020. 
6. Beckett NS Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. 
Treatment of Hypertension in Patients 80 Years of Age or Older. New 
England Journal of Medicine. 2008;358:1887-1898. 
7. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline 
for the Prevention, Detection, Evaluation, and Management of High Blood 
Pressure in Adults, A Report of the American College of 
Cardiology/American Heart Association Task Force on Clinical Practice 
Guidelines; J Amer Col Cardiol.  2017 
www.onlinejacc.org/content/early/2017/11/04/j.jacc.2017.11.006.extract.
jpg17  
   
